Maternal immune suppression during pregnancy does not prevent abnormal behavior in offspring

Maternal immune suppression during pregnancy does not prevent abnormal behavior in offspring

Abstract Background Offspring of hypertensive disorders of pregnancy are at an increased risk of developing neurodevelopmental and neurobehavioral disorders compared to offspring from non-affected pregnancies. Using rodent models of Preeclampsia (PreE; new onset of hypertension after 20 weeks gestat...

Full description

Bibliographic Details
Main Authors:	Ashley Griffin, Teylor Bowles, Lucia Solis, Teryn Railey, Samer Beauti, Reanna Robinson, Shauna-Kay Spencer, James P Shaffery, Kedra Wallace
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	Biology of Sex Differences
Subjects:	sFlt-1 Preeclampsia HELLP syndrome ADHD Neurodevelopment Hypertensive disorders of pregnancy
Online Access:	https://doi.org/10.1186/s13293-024-00600-8

Similar Items

Evidence of Anxiety, Depression and Learning Impairments following Prenatal Hypertension
by: Kedra Wallace, et al.
Published: (2022-02-01)

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019-07-01)

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
by: Natasha de Alwis, et al.
Published: (2022-08-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Intraperitoneal Injection of High Tumor Necrosis Factor (TNF- α ) Serum Increase Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Blood Pressure of Pregnant Mice
by: Bramantyo Aji Wicaksono, et al.
Published: (2015-05-01)

Growth-Restricted Fetuses and Offspring Reveal Adverse Sex-Specific Metabolic Responses in Preeclamptic Mice Expressing Human sFLT1
by: Rebekka Vogtmann, et al.
Published: (2023-04-01)

Nitroxide—HMP—Protects Human Trophoblast HTR-8/SVneo Cells from H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway
by: Diana Pintye, et al.
Published: (2023-08-01)

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
by: Evangeline Deer, et al.
Published: (2021-10-01)

Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia
by: Rahana Abd Rahman, et al.
Published: (2020-04-01)

Overexpression of Human sFLT1 in the Spongiotrophoblast Is Sufficient to Induce Placental Dysfunction and Fetal Growth Restriction in Transgenic Mice
by: Rebekka Vogtmann, et al.
Published: (2024-02-01)

sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
by: Kamil Pluta, et al.
Published: (2024-01-01)

Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
by: Bianca R. Fato, et al.
Published: (2022-09-01)

Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study
by: David B. Seifer, et al.
Published: (2022-01-01)

Pro-angiogenic therapeutics for preeclampsia
by: Adrian C. Eddy, et al.
Published: (2018-08-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
by: Evelyn A. Huhn, et al.
Published: (2018-11-01)

A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia—A Proof-of-Principle Study in a Murine Model
by: Diana Pintye, et al.
Published: (2023-11-01)

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
by: Lissette Carolina Sanchez-Aranguren, et al.
Published: (2020-07-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
by: Roxanne Hastie, et al.
Published: (2022-08-01)

Impact of Postpartum Dexamethasone on Postpartum Disease Stabilization in Women with HELLP Syndrome
by: Ayla Sargın Oruç, et al.
Published: (2016-01-01)

VEGF Maintains Maternal Vascular Space Homeostasis in the Mouse Placenta through Modulation of Trophoblast Giant Cell Functions
by: Xiujun Fan, et al.
Published: (2021-07-01)

Validation of a new kit for preeclampsia screening: A comprehensive analysis
by: Min Zhu, et al.
Published: (2024-03-01)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
by: Valentina Giardini, et al.
Published: (2023-10-01)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
by: Masaru Matsui, et al.
Published: (2022-11-01)

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders
by: Jonathan Baert, et al.
Published: (2021-07-01)

New Approaches for Preeclampsia: Review of the Literature
by: Emel Ebru Özçimen
Published: (2016-01-01)

Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection
by: Valentina Giardini, et al.
Published: (2022-10-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
by: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Published: (2023-05-01)

Calcitonin gene-related peptide protects from soluble fms-like tyrosine kinase-1-induced vascular dysfunction in a preeclampsia mouse model
by: Akansha Mishra, et al.
Published: (2023-08-01)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
by: Alice Hoeller, et al.
Published: (2017-04-01)

Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
by: Xiaohe Zhu, et al.
Published: (2020-10-01)

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19
by: Salvador Espino-y-Sosa, et al.
Published: (2021-09-01)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
by: Xinwen Chang, et al.
Published: (2023-08-01)

Can Similarities between the Pathogenesis of Preeclampsia and COVID-19 Increase the Understanding of COVID-19?
by: Valentina Giardini, et al.
Published: (2022-05-01)

Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model
by: Jing Zhou, et al.
Published: (2015-06-01)

INVESTIGATION OF SFLT-1 AND VEGF EXPRESSION IN NORMOTENSIVE AND PREECLAMPTIC PLACENTA. AN IMMUNOHISTOCHEMICAL STUDY
by: Ugur Seker
Published: (2020-12-01)

Partial HELLP Syndrome: maternal and perinatal outcome
by: Joelcio Francisco Abbade, et al.

Maternal Serum Angiogenic Profile and Its Correlations with Ultrasound Parameters and Perinatal Results in Normotensive and Preeclamptic Pregnancies Complicated by Fetal Growth Restriction
by: Weronika Dymara-Konopka, et al.
Published: (2023-06-01)